Actinium Pharmaceuticals (ATNM) Shares Issued (2013 - 2026)
Actinium Pharmaceuticals (ATNM) posted quarterly Shares Issued of $129000.0 for Q1 2026, up 47501.48% year-over-year from N/an in Q1 2025, and up 30.3% quarter-over-quarter from $99000.0 in Q4 2025.
Actinium Pharmaceuticals (ATNM) Shares Issued (2013 - 2026) Analysis & Trends
Actinium Pharmaceuticals (ATNM) has reported Shares Issued for 14 consecutive years, with $129000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued rose 47501.48% year-over-year to $129000.0; the TTM figure through Mar 2026 stood at $129000.0 (up 47501.48% YoY), while the FY2025 annual figure was $99000.0, down 98.07% from the prior year.
- Shares Issued rose to $129000.0 in Q1 2026 per ATNM's latest filing, from $99000.0 in the prior quarter.
- Across five years, Shares Issued topped out at $5.4 million in Q4 2023 and bottomed at $166.0 in Q2 2025.
- Historically, Shares Issued has averaged $906920.6 across 5 years, with a median of $5216.0 in 2024.
- Annual changes were most pronounced in 2022 — Shares Issued slumped 99.95% — and 2023, when it soared 800863.86%.
- Actinium Pharmaceuticals' Shares Issued stood at $3396.0 in 2022, then soared by 160235.69% to $5.4 million in 2023, then dropped by 5.66% to $5.1 million in 2024, then sank by 98.07% to $99000.0 in 2025, then soared by 30.3% to $129000.0 in 2026.
- Business Quant data shows ATNM's Shares Issued at $129000.0 in Q1 2026, $99000.0 in Q4 2025, and $134000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Actinium Pharmaceuticals | 35.01 Mn | 35.01 Mn | - | 379,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 379,000.00 |
| Jun 30, 2026 | 379,000.00 |
| Mar 31, 2026 | 129,000.00 |
| Mar 31, 2026 | 129,000.00 |
| Dec 31, 2025 | 99,000.00 |
| Dec 31, 2025 | 99,000.00 |
| Sep 30, 2025 | 134,000.00 |
| Sep 30, 2025 | 134,000.00 |
| Jun 30, 2025 | 166.00 |
| Jun 30, 2025 | 166.00 |
| Mar 31, 2025 | 271.00 |
| Mar 31, 2025 | 271.00 |
| Dec 31, 2024 | 5.14 Mn |
| Dec 31, 2024 | 5.14 Mn |
| Sep 30, 2024 | 5,216.00 |
| Sep 30, 2024 | 5,216.00 |
| Jun 30, 2024 | 5,420.00 |
| Jun 30, 2024 | 5,420.00 |
| Mar 31, 2024 | 1,797.00 |
| Mar 31, 2024 | 1,797.00 |